John A. Kessler
17Patents
10h-index
12Co-inventors
69Inventor score
Filing activity: Feb 6, 1991 → Oct 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585348A | Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia | Emerging Cross-Sectional Technologies | 115 | Expired |
| US5648335A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 106 | Expired |
| US5569648A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 74 | Expired |
| US5420112A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5633228A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5604202A | Use of NGF growth factors to treat drug-induced neuropathy | Human Necessities | 27 | Expired |
| US6011004A | Use of growth factors to treat drug-inducted neuropathy | Human Necessities | 26 | Expired |
| US8966822B2 | Air and debris dam for moving coil balance assembly | Fixed Constructions | 19 | Active |
| US5357722A | Insulation system | Fixed Constructions | 12 | Expired |
| US9181748B2 | Air and debris dam for moving coil balance assembly | Fixed Constructions | 10 | Active |
| US5564250A | Insulation system | Fixed Constructions | 3 | Expired |
| US8524655B2 | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders | Human Necessities | 3 | Active |
| US8796022B2 | Generation of functional basal forebrain cholinergic neurons from stem cells | Chemistry; Metallurgy | 2 | Active |
| US9982469B2 | Pivot bar for window sash | Fixed Constructions | 1 | Active |
| US11851490B2 | Methods and compositions for treating, inhibiting, and/or preventing heterotopic ossification | Chemistry; Metallurgy | 0 | Active |
| US8697048B2 | Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells | Human Necessities | 0 | Active |
| US11696896B2 | Immunomodulatory nanoparticle treatment of brain injury | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.